Table 1.
Author | Year | Patients (n value) | Hand cases | Male (%) | Primary cancer (all cases) | Hand lesions | Survival (all cases)a | MINORS score |
---|---|---|---|---|---|---|---|---|
Healey et alA483 | 1986 | 27 | 18 | NM | Lung (5), kidney (5), esophagus (4), colorectal (3), breast (2), ovary (2), prostate (2), bone (2), bladder (1), uterus (1), thyroid (1), unknown (1) | Trapezium (1), hamate (1), lunate (1), triquetrum, 1MC (1), 2MC (2), 3MC (1), 4MC (3), 5MC (2), (1)1DP (1), 1PP (2), 2PP (1), 3DP (1), 4DP (1), 4PP (1) 5DP (1) | 8.4 ± 8.5 | 7 |
Leeson et alA484 | 1986 | 57 | 5 | 29 (50.9%) | Lung (17), kidney (8), neuroblastoma (5), prostate (4), thyroid (3), stomach (3), cervix (2), skin (2), breast (1), retinoblastoma (1), liver (1), rhabdomyosarcoma (1) | 5 “hand” | 6.7 (1-28) | 7 |
Amandio and LombardiA485 | 1987 | 18 | 18 | 14 (77.8%) | Lung (5), kidney (5), breast (1), head and neck (3), femur (1), humerus (1), colorectal (1) | 1PP (1), 1DP (3), 2PP (1), 2DP (1), 3DP (4), 4DP(3), 5DP (1), 2MC (1), capitate (1), scaphoid (1), lunate (1), palm (ST)(2), dorsum of hand (ST)(2) | 5.0 | 12 |
Libson et alA486 | 1987 | 21 | 21 | 13 (61.9%) | Lung (13), breast (4), kidney (1), prostate (1), colon (1), unknown (1) | “Carpal” (2), “Metacarpal” (5), “Phalange” (4), “Distal phalanx” (3), scaphoid (1), 3MC (1), 1PP (1), 1DP (3), 2PP (1), 2MP (1), 2DP (1), 3MP (1), 4MP (1), 4DP (1) | NM | 6 |
Morris et alA487 | 2017 | 10 | 10 | 7 (70%) | Lung (4), skin (3), kidney (2), neuroendocrine (1) | Carpals (1), MCs (7), phalanges (5) | 18 (5-138) | 12 |
El Abiad et alA488 | 2019 | 28 | 12 | 16 (57.1%) | Lung (9), kidney (5), prostate (4), breast (2), soft tissue sarcoma (2), chondrosarcoma (1), squamous cell carcinoma (1), thyroid (1), metastatic chondroid syringoma (1), phosphaturic mesenchymal tumor (1) | Carpals (2), MCs (6), phalanges (6) | 7.7 (1.3-144) | 10 |
Tani et alA489 | 2020 | 11 | NM | 6 (54.5%) | Kidney (4), other (3), breast (2), colon (1), stomach (1) | Unclear | 6.5 | 7 |
Note. A“reference number” = Citation for the reviewed article can be found in Supplemental Appendix B. MINORS = methodological index for non-randomized studies; M = male; F = female; NM = not mentioned; MC = metacarpal; DP = distal phalanx; PP = proximal phalanx; (ST) = indicates a soft tissue lesion; MP = middle phalanx; NS = no side mentioned.
Mean, +/- SD or range in months if provided.